Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

716
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
716
Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

4.4K
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
4.4K
Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

8.7K
In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
8.7K
Bonferroni Test01:10

Bonferroni Test

2.6K
The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
2.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Margin of Error01:27

Margin of Error

6.2K
The margin of error is also called the maximum error of an estimate. The margin of error is the maximum possible or expected difference between the observed sample parameter value and the actual population parameter value. For proportion, it is the maximum difference between the value of sample proportion obtained from the data and the true value of population proportion. As the true value of the population parameter is not known, the margin of error is calculated using the sample statistic.
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trial.

Breast (Edinburgh, Scotland)·2026
Same author

A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications.

Frontiers in medicine·2025
Same author

Closed MCP-Mod for Pairwise Comparisons of Several Doses With a Control.

Statistics in medicine·2025
Same author

Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?

Neuro-oncology practice·2025
Same author

Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).

Nature cancer·2025
Same author

A general consonance principle for closure tests based on <math><mi>p</mi></math>-values.

Statistical methods in medical research·2024

Related Experiment Video

Updated: May 1, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.1K

Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications.

Alexandra C Graf1, Peter Bauer, Ekkehard Glimm

  • 1Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria; Competence Center for Clinical Trials, University of Bremen, Linzer Strasse 4, 28359, Bremen, Germany.

Biometrical Journal. Biometrische Zeitschrift
|April 23, 2014
PubMed
Summary

Adaptive designs with sample size modifications can inflate type 1 error rates. Fixing control group sample size in interim analyses helps maintain statistical validity for multi-arm trials.

Keywords:
Conditional error functionInterim analysisMaximum type 1 errorSample size reassessmentTreatment selection

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Related Experiment Videos

Last Updated: May 1, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Area of Science:

  • Biostatistics
  • Clinical Trial Design

Background:

  • Adaptive clinical trial designs allow for modifications during the study.
  • Sample size adjustments and allocation ratio changes can inflate the type 1 error rate if not handled properly.

Purpose of the Study:

  • To investigate type 1 error rate inflation in adaptive designs with multiple treatment arms.
  • To evaluate the impact of sample size and allocation ratio modifications during interim analyses.
  • To assess statistical procedures for controlling type 1 error rates in complex adaptive designs.

Main Methods:

  • Quantified type 1 error inflation using naive and Dunnett procedures.
  • Identified worst-case scenarios for sample size adaptation rules.
  • Investigated unconstrained and constrained second-stage sample size modifications.

Main Results:

  • Unconstrained sample size modifications can lead to significant type 1 error rate inflation.
  • The naive procedure and Dunnett procedure show varying degrees of inflation.
  • Constraining second-stage sample sizes, such as fixing the control group size, can control type 1 error rates.

Conclusions:

  • Adaptive designs require careful handling of sample size modifications to prevent type 1 error inflation.
  • Fixing the control group sample size in adaptive multi-arm trials is a viable strategy for maintaining statistical integrity.